News Category
The DEA will hold a hearing in June on reclassifying marijuana under federal law, drawing interest from both sides of the legalization debate and sign...
Jupiter Neurosciences closed a $2 million registered direct offering to fund its CNS pipeline, including a Phase IIa trial for Parkinson's disease and...
Optimi Health Corp. has priced a $15 million underwritten public offering of 2.4 million shares at $6.25 each, with trading on Nasdaq expected to begi...
A new global report from the Global Cannabis Network Collective and Whitney Economics analyzes pricing compression as a critical and often misundersto...
The potential rescheduling of marijuana could allow cannabis businesses to deduct expenses, freeing up capital for expansion and potentially increasin...
A new congressional report outlines the potential benefits and limitations of the Trump administration's move to reclassify cannabis, providing clarit...
Republican lawmakers on a key House committee are advancing a spending proposal that could halt federal efforts to reschedule cannabis, threatening th...
Cannabis retailers across the U.S. saw a notable sales surge on April 20, with strong gains in newly legal states, offering key data for firms like Tr...
President Trump's executive order to reclassify marijuana from Schedule 1 to Schedule 3 could transform cannabis business finances and investment oppo...
